An interventional study of Adductor-Canal-Blockade and Femoral Nerve Block in Total Knee Arthroplasty, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to participants aged 50 Years to 85 Years. Per ClinicalTrials.gov, last updated 2012-12-18.
Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Treatment
The aim of this study is to investigate the efficacy of the Adductor-Canal-Blockade versus the Femoral Nerve Block on muscle strength, pain and mobilization after total knee arthroplasty. We hypothesize that the Adductor-Canal-Blockade has the same effect on pain and morphine consumption as the Femoral Nerve Block, but without the same reduction in quadriceps muscle strength.
Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Adductor-Canal-Blockade
Procedure: Femoral Nerve Block
US-guided Adductor-Canal-Blockade with Ropivacaine
US-guided Femoral Nerve Block with Ropivacaine
The difference in quadriceps muscle strength between the Adductor-Canal-Blockade and the femoral nerve block
Time frame: 24 h postoperatively
The difference in adductor muscle strength between the Adductor-Canal-Blockade and the Femoral Nerve Block
Time frame: 24 h postoperatively
Pain during flexion of the knee
0-100 mm at a visual analogue scale (VAS), calculated as the area under the curve for the interval 2-24 hours postoperatively.
Time frame: 2-24 hours
Pain at rest
0-100 mm at a visual analogue scale (VAS), calculated as the area under the curve for the interval 2-24 hours postoperatively.
Time frame: 2-24 hours
Total morphine consumption
Time frame: 0-24 hours
Postoperative nausea
Time frame: 2-24 hours
Postoperative vomiting
Time frame: 0-24 hours
Sedation
Time frame: 2-24 hours
Zofran consumption
Number of patients recieveing zofran postoperatively
Time frame: 0-24 hours
The difference in mobilization between the groups
Time frame: 24 hours
This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rigshospitalet, Denmark